RH
Roche Holding AG
RHHBY · OTC
$54.30 -0.61% (-$0.33)
1M -6.20%
Market Cap CHF 286.7B
P/E Ratio 22.26x
Div. Yield 2.84%
ROE 40.61%
Bulios Fair Price
$36.14
33.4% downside
Trenutna cena
$54.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica RHHBY trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Moderate
5/9Valuation
52 /100
Fair P/E 22.26x
PEG 0.40x
EV/EBITDA 14.41x
Growth
25 /100
Declining EPS growth 0.17%
Book val. growth 6.53%
Rev. growth 1.26%
Profitability
100 /100
Strong Gross margin 73.73%
FCF margin 21.23%
Net margin 20.33%
Quality
92 /100
Excellent ROIC 19.71%
Asset turnover 0.63x
ROE 40.61%
Debt
75 /100
Low Debt/Equity 0.94x
Net debt/EBITDA 1.20x
Current ratio 1.38x
Stability
70 /100
Stable Beta 0.35x
Profitable years 6
Rev. volatility 6.15%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RHHBY
Online
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Thomas Schinecker
Employees
103,249
Headquarters
Basel
Prihajajoči dogodki
04 FEB.
Earnings
Upcoming earnings report